Dashboard
Manage Tickers

ZLABZai Lab Ltd

Nasdaq zailaboratory.com


$ 16.04 $ 0.13 (0.82 %)    

Monday, 29-Apr-2024 09:41:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.63 $ -1.52 (-0.35 %)
DIA $ 383.22 $ 0.09 (0.02 %)
SPY $ 509.60 $ -0.66 (-0.13 %)
TLT $ 88.54 $ -0.14 (-0.16 %)
GLD $ 215.81 $ -0.29 (-0.13 %)
$ 15.91
$ 16.07
$ 0.00 x 0
$ 0.00 x 0
$ 16.04 - $ 16.07
$ 13.48 - $ 39.50
364,581
na
15.38B
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-27-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

one-good-one-bad-news-for-bristol-myers-squibbs-marketed-drugs-details
One Good, One Bad News For Bristol Myers S...
04/01/2024 13:44:31

Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint...

Core News & Articles
Zai Lab Shares Higher; Co Noted Partner B...
04/01/2024 11:34:31

Core News & Articles
Novocure Announces METIS Phase 3 Clinical ...
03/27/2024 13:30:21

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with Tumor Treating Field...

stock-disconnect-triggers-investor-exodus-from-cstone-pharma
Stock Disconnect Triggers Investor Exodus ...
03/14/2024 18:48:29

Key Takeaways: CEO Jason Yang has increased his CStone stake multiple times over the past 18 months to 4.79% of outstanding ...

zai-lab-to-present-findings-from-preclinical-studies-highlighting-zl-1310-a-novel-antibody-drug-conjugate-adc-for-treatment-of-solid-tumors
Zai Lab To Present Findings From Preclinic...
03/14/2024 06:38:31

ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung cancer and other DLL3+ solid t...

zai-lab-to-present-final-overall-survival-dataffrom-phase-3-nora-study-of-zejula-in-platinum-sensitive-recurrent-ovarian-cancer
Zai Lab To Present Final Overall Survival ...
03/06/2024 21:12:54

- Findings will be shared in oral presentations at the 2024 Congress of the European Society of Gynaecological Oncology (ESGO) ...

citigroup-maintains-buy-on-zai-lab-lowers-price-target-to-66
Citigroup Maintains Buy on Zai Lab, Lowers...
02/29/2024 17:18:10

Citigroup analyst Yigal Nochomovitz maintains Zai Lab (NASDAQ:ZLAB) with a Buy and lowers the price target from $123 to $66.

recap-zai-lab-q4-earnings
Recap: Zai Lab Q4 Earnings
02/27/2024 21:55:38

zai-lab-q4-2023-gaap-eps-098-misses-086-estimate-sales-6583m-miss-7346m-estimate
Zai Lab Q4 2023 GAAP EPS $(0.98) Misses $(...
02/27/2024 21:51:40

Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $(0.86) by ...

earnings-scheduled-for-february-27-2024
Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

top-5-health-care-stocks-that-are-preparing-to-pump-in-february
Top 5 Health Care Stocks That Are Preparin...
02/09/2024 13:35:36

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

zai-lab-said-on-feb-5-entered-into-uncommitted-facility-letter-with-the-bank-of-china-hong-kong-limited-said-bank-will-provide-standby-letters-of-credit-for-loans-of-up-to-100m-for-term-of-one-year
Zai Lab Said On Feb 5, Entered Into Uncomm...
02/08/2024 21:46:26

-8-K

archer-daniels-midland-b-riley-financial-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Archer-Daniels-Midland, B. Riley Financial...
01/22/2024 10:07:25

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Da...

zai-lab-says-the-new-england-journal-of-medicine-published-data-demonstrating-durable-clinical-activity-of-repotrectinib-in-patients-with-advanced-ros1-fusion-positive-nsclc
Zai Lab Says The New England Journal Of Me...
01/10/2024 22:13:45

what-happened-with-zai-lab-stock
What Happened With Zai Lab Stock?
12/21/2023 21:12:03

Zai Lab Limited (NASDAQ: ZLAB) shares traded lower on Thursday. The stock has pulled back sharply from recent strength.

paychex-reports-downbeat-sales-joins-blackberry-and-other-big-stocks-moving-lower-on-thursday
Paychex Reports Downbeat Sales, Joins Blac...
12/21/2023 16:02:00

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday.

morgan-stanley-initiates-coverage-on-zai-lab-with-overweight-rating-announces-price-target-of-475
Morgan Stanley Initiates Coverage On Zai L...
12/14/2023 10:51:43

Morgan Stanley analyst Jack Lin initiates coverage on Zai Lab (NASDAQ:ZLAB) with a Overweight rating and announces Price Tar...

zai-lab-earlier-announced-that-the-2023-national-reimbursement-drug-list-released-by-chinas-national-healthcare-security-administration-has-been-updated-to-include-vyvgart-nuzyra-and-zejula
Zai Lab Earlier Announced That The 2023 Na...
12/13/2023 13:56:40

VYVGART® (efgartigimod alfa injection) is included for the first time in the NRDL for the treatment of adult patients with gene...

zai-lab-announces-inclusion-of-vyvgart-and-other-medicines-in-chinas-2023-national-reimbursement-drug-list
Zai Lab Announces Inclusion Of VYVGART And...
12/13/2023 06:54:34

Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)))) today announced that the 2023 National Reimbursement Drug List (NRDL) released by ...

why-bluebird-bio-shares-are-trading-higher-here-are-other-stocks-moving-in-mondays-mid-day-session
Why bluebird bio Shares Are Trading Higher...
12/11/2023 18:12:59

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION